CCDC6 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.166400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.034360E-01
Normal-vs-Stage2
2.619000E-01
Normal-vs-Stage3
4.203900E-02
Normal-vs-Stage4
2.472600E-01
Stage1-vs-Stage2
6.218200E-01
Stage1-vs-Stage3
2.522400E-01
Stage1-vs-Stage4
8.462400E-01
Stage2-vs-Stage3
1.104570E-01
Stage2-vs-Stage4
8.405600E-01
Stage3-vs-Stage4
2.936000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.089200E-01
Normal-vs-AfricanAmerican
4.530600E-01
Normal-vs-Asian
1.248550E-01
Caucasian-vs-AfricanAmerican
5.628200E-01
Caucasian-vs-Asian
7.085600E-01
AfricanAmerican-vs-Asian
4.445800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.490200E-01
Normal-vs-Female
1.646780E-01
Male-vs-Female
6.641600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.989600E-01
Normal-vs-Age(41-60Yrs)
4.739400E-01
Normal-vs-Age(61-80Yrs)
1.303780E-01
Normal-vs-Age(81-100Yrs)
3.447700E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.122800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.556600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.985800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.022800E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.928000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.637000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.491800E-01
Normal-vs-Daily Drinker
4.885600E-01
Normal-vs-Weekly Drinker
1.599560E-01
Normal-vs-Occasional Drinker
1.485820E-01
Normal-vs-Social Drinker
2.868800E-01
Non Drinker-vs-Daily Drinker
6.061000E-01
Non Drinker-vs-Weekly Drinker
7.019200E-01
Non Drinker-vs-Occasional Drinker
8.378400E-01
Non Drinker-vs-Social Drinker
8.172400E-01
Daily Drinker-vs-Weekly Drinker
4.692400E-01
Daily Drinker-vs-Occasional Drinker
7.328000E-01
Daily Drinker-vs-Social Drinker
8.116400E-01
Weekly Drinker-vs-Occasional Drinker
5.390000E-01
Weekly Drinker-vs-Social Drinker
5.771000E-01
Occasional Drinker-vs-Social Drinker
9.531800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.999900E-02
Normal-vs-Grade 2
6.082700E-03
Normal-vs-Grade 3
5.117300E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.450160E-02
Grade 1-vs-Grade 3
4.238600E-03
Grade 1-vs-Grade 4
8.999900E-02
Grade 2-vs-Grade 3
2.469600E-01
Grade 2-vs-Grade 4
6.082700E-03
Grade 3-vs-Grade 4
5.117300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.154810E-01
Normal-vs-NonDiabetic
2.345800E-01
Diabetic-vs-NonDiabetic
1.848990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.122400E-01
Normal-vs-NoPancreatitis
2.068000E-01
Pancreatitis-vs-NoPancreatitis
2.448800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.275800E-02
Normal-vs-N1
3.117200E-01
N0-vs-N1
7.682400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.958800E-01
Normal-vs-TP53-NonMutant
4.268600E-01
TP53-Mutant-vs-TP53-NonMutant
6.196100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
